Innovating Obesity Drug Discovery: Trends, Challenges, and Translational Strategies скачать в хорошем качестве

Innovating Obesity Drug Discovery: Trends, Challenges, and Translational Strategies

Obesity is a complex, multifactorial disease that presents major hurdles for drug discovery and development. While advances in incretin-based therapies and novel metabolic targets have made progress, translating early discoveries into safe, effective, and lasting treatments remains a significant challenge. In this webinar, hear from Andrew Grottick and Luke Oostdyk of Eurofins Discovery as they examine the evolving landscape of obesity drug discovery - focusing on emerging scientific trends, unmet medical needs, and key translational challenges. They will also discuss how integrated strategies - spanning target validation, in vitro biology, medicinal chemistry, ADME/PK, and in vivo efficacy models - can accelerate development and reduce risk across the discovery pipeline. Through real-world case studies and collaborative insights, this webinar will explore how end-to-end discovery tools can support the development of next-generation obesity therapeutics. Whether focused on early-stage target exploration or progressing candidates toward the clinic, attendees will gain practical perspectives on addressing the complexity of obesity drug discovery with greater clarity and confidence.